Vectors expressing HIV antigens and GM-CSF and related methods for generating an immune response

Details for Australian Patent Application No. 2011217955 (hide)

Owner Emory University of Technology Transfer Geovax, Inc.

Inventors Robinson, Harriet L.; Amara, Rama R.; Hellerstein, Michael; Lai, Lilin

Agent Shelston IP

Pub. Number AU-A-2011217955

PCT Pub. Number WO2011/103417

Priority 61/387,801 29.09.10 US; 61/305,936 18.02.10 US

Filing date 18 February 2011

Wipo publication date 25 August 2011

International Classifications

C12N 15/49 Mutation or genetic engineering

A61K 39/21 Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 15/79 Mutation or genetic engineering - Vectors or expression systems specially adapted for eukaryotic hosts

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/103417 Priority application(s): WO2011/103417

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011217960-Apparatus and methods for providing information about one or more subterranean variables

2011217954-Generation of a hedgeable index and market making for a hedgeable index-based financial instrument